HMGB1 and diabetes mellitus: In animal experiments, it was demonstrated that inhibition of extracellular HmgB1 attenuates inflammation and increase the organism defenses against several diseases (including sepsis [210], diabetes [211], ischemia, and damage to the heart and liver [212,213]).